1. Sci Rep. 2019 Jun 21;9(1):9054. doi: 10.1038/s41598-019-45389-4.

Genetic markers of lipid metabolism genes associated with low susceptibility to 
HCV infection.

Real LM(1)(2), Macías J(3), Rivero-Juárez A(4), Téllez F(5), Merino D(6), 
Moreno-Grau S(7), Orellana A(7), Gómez-Salgado J(8), Sáez ME(9), Frías M(4), 
Corma-Gómez A(3), Merchante N(3), Ruiz A(7), Caruz A(10), Pineda JA(3); GEHEP 
012 study group.

Collaborators: Fernández-Fuertes M, Iglesias M, Rincón P.

Author information:
(1)Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital 
Universitario de Valme, Sevilla, Spain. lmreal67b@gmail.com.
(2)Departamento de Bioquímica, Biología Molecular e Inmunología, Facultad de 
Medicina, Universidad de Malaga, Málaga, Spain. lmreal67b@gmail.com.
(3)Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital 
Universitario de Valme, Sevilla, Spain.
(4)Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBC), Hospital 
Universitario Reina Sofía de Córdoba, Universidad de Córdoba, Cordoba, Spain.
(5)Hospital Universitario de Puerto Real, Instituto de Investigación e 
Innovación de la Provincia de Cádiz, Cádiz, Spain.
(6)Unidad de Enfermedades Infecciosas, Hospital Universitario Juan Ramón 
Jiménez, Huelva, Spain.
(7)Fundació ACE-Institut Català de Neurociències Aplicades, Universidad 
Internacional de Catalunya (UIC), Barcelona, Spain.
(8)Universidad Espiritu Santo, Guayaquil, Ecuador.
(9)Centro Andaluz de Estudios Bioinformáticos (CAEBI, SL), Sevilla, Spain.
(10)Unidad de Inmunogenética, Universidad de Jaén, Jaén, Spain.

Due to the relation between lipids and Hepatitis C virus (HCV) life-cycle, we 
aimed to explore the existence of single nucleotide polymorphisms (SNPs) 
associated with low susceptibility to HCV-infection within lipid metabolism 
genes. This was a case-control study in three phases: (I) allelic frequencies of 
9 SNPs within 6 genes were compared in 404 HCV-infected patients and 801 
population controls; (II) results were validated in 602 HCV-infected individuals 
and 1352 controls; (III) results were confirmed in 30 HCV-exposed uninfected 
(EU) individuals. In phase I, only the LDLRAP1-rs4075184-A allele was 
differentially distributed in patients and controls (358 of 808 alleles [44.3%] 
and 807 of 1602 alleles [50.3%], respectively) (p = 0.004). In phase II, the A 
allele frequency was 547 of 1204 alleles (45.4%) in patients and 1326 of 2704 
alleles (49.0%) in controls (p = 0.037). This frequency in EU was 36 of 60 
alleles (60%), which was higher than that observed in patients from phase I 
(p = 0.018) and phase II (p = 0.027). The LDLRAP1-mRNA expression was lower in 
AA carriers than in non-AA carriers (median [Q1-Q3]: 0.85 [0.17-1.75] 
relative-units [ru] versus 1.71 [1.00-2.73] ru; p = 0.041). Our results suggest 
that LDLRAP1-rs4075184-A allele is associated with lower susceptibility to 
HCV-infection and with reduced expression of LDLRAP1-mRNA.

DOI: 10.1038/s41598-019-45389-4
PMCID: PMC6588564
PMID: 31227787 [Indexed for MEDLINE]

Conflict of interest statement: The authors declare no competing interests.